---
title: "Aclaris Therapeutics, Inc. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/1ced63b0-706e-496b-81fa-5e662b8a6b6c
json: https://whiteintel.dev/api/public/dossier/1ced63b0-706e-496b-81fa-5e662b8a6b6c
identifier: psc:LLxp1OOY8zVP5BRvMslE6iAQrNA
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Aclaris Therapeutics, Inc.

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `psc:LLxp1OOY8zVP5BRvMslE6iAQrNA`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/1ced63b0-706e-496b-81fa-5e662b8a6b6c  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/1ced63b0-706e-496b-81fa-5e662b8a6b6c  

## Ownership & control

### Holdings / subsidiaries

- **Aclaris Therapeutics, Inc.** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/362db47c-1048-5b36-a176-c9e45e7baf24

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Aclaris Therapeutics, Inc.**. Human view: https://whiteintel.dev/entity/1ced63b0-706e-496b-81fa-5e662b8a6b6c · Structured JSON: https://whiteintel.dev/api/public/dossier/1ced63b0-706e-496b-81fa-5e662b8a6b6c._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._